1887

Abstract

Summary

We have developed a flow cytometric method for demonstrating cell fusion between human immunodeficiency virus type 1 (HIV-1)- or HIV-2-infected HUT-78 cells and uninfected CD4-bearing MOLT-4 cells. Syncytium formation due to an interaction between the gp120 glycoprotein expressed on HIV-infected HUT-78 cells and the CD4 receptor present on MOLT-4 cells, resulted in an immediate decrease in the number of MOLT-4 cells; after a 24 h incubation period almost all MOLT-4 cells had disappeared from the culture. To show that the target MOLT-4 cells and not the aggressor HUT-78 cells were destroyed, specific monoclonal antibodies (MAbs) that reacted with antigens expressed on either MOLT-4 or HUT-78 cells were used. The formation of giant cells andthe concomitant disappearance of MOLT-4 cells was blocked by MAbs specific for OKT4A and Leu3a, and, to a much lower level, by the MAbs specific for OKT4 and gp120. MAbs specific for OKT3,Leu2a, HLA-DR, Leu18 and LeuM3 did not prevent the disappearance of MOLT-4 cells. Sera from two AIDS patients containing antibodies to the HIV envelope glycoproteins did not protect MOLT-4cells against the destructive effect of the HIV-infected HUT-78 cells. The fusion index, thepercentage fusion inhibition and the 50% fusion inhibitory concentration of the MAbs can be accurately determined with the flow cytometric assay. The method can be readily implemented to evaluate any therapeutic treatment by examining its capacity to block cell-to-cell fusion, and hence destruction of the target bystander cells. Five anti-HIV compounds which have been previously shown to interfere with HIV binding to cells (namely pentosan polysulphate, heparin, suramin, aurintricarboxylic acid and Evans Blue) were further evaluated by this new method. With the exception of heparin, all of these compounds were found to inhibit cell-to-cell fusion andthe concomitant destruction of the target bystander cells. Azidothymidine failed to inhibit fusion or bystander T cell destruction.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-70-9-2397
1989-09-01
2021-10-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/70/9/JV0700092397.html?itemId=/content/journal/jgv/10.1099/0022-1317-70-9-2397&mimeType=html&fmt=ahah

References

  1. Baba M., Nakajima M., Schols D., Pauwels R., Balzarini J., De Clercq E. 1988a; Pentosan polySulfate, a sulfated oligosaccharide, is a potent and selective anti-HIV agent in vitro. Antiviral Research 9:335–343
    [Google Scholar]
  2. Baba M., pauwels R., Balzarini J., Arnout J., Desmyter J., De clercq E. 1988b; Mechanism of inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus in vitro. Proceedings of the National Academy of SciencesU.S.A. 85:6132–6136
    [Google Scholar]
  3. Baba M., Schols D., Pauwels R., Balzarini J., De Clercq E. 1988c; Fuchsin acid selectively inhibits human immunodeficiency virus (HIV) replication in vitro. Biochemical and Biophysical Research Communications 155:1404–1411
    [Google Scholar]
  4. Balzarini J., Mitsuya D., De clercq E., Broder S. 1986; Aurintricarboxylic acid and Evans Blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus. Biochemical and Biophysical Research Communications 136:64–71
    [Google Scholar]
  5. Barrésinoussi F., Chermann J. C., Rey F., Nugeyre M. T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vezinet-Brun F., Rouzioux C., Rozenbaum W., Montagnier L. 1983; Isolation of a T lymphotropic retrovirus from a patient at risk for AIDS. Science 220:868–871
    [Google Scholar]
  6. Dalgleish A. G., Beverley P. C. L., Clapham P. R., Crawford D. H., Greaves M. P., Weiss R. A. 1984; The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature, London 312763–766
    [Google Scholar]
  7. Haseltine W. B. 1988; Replication and pathogenesis of the AIDS virus. Journal of Acquired Immune Deficiency Syndromes 1:217–240
    [Google Scholar]
  8. Klatzmann D., Barré-sinoussi F., Nugeyre M. T., Dauguet C., Vilmer E., Griscelli C., Brun-Vezinet F., Rouzioux C., Gluckman J.C., Chermann J. C., Montagnier L. 1984; Selective tropism of LAV for helper T lymphocytes. Science 225:59–63
    [Google Scholar]
  9. Kowalski M., Potz J., Basiripour L., Dorfman T., Goh W.C., Terwilliger E., Dayton A., Rosen C., Haseltine W., Sodroski J. 1987; Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237:1351–1355
    [Google Scholar]
  10. Lifson J. D., Reyes G. R., Mcgrath M. S., Stein B. S., Engleman E. G. 1986a; AIDS retrovirus induced cytopathogenicity: giant cell formation and involvementof CD4 antigen. Science 232:1123–1127
    [Google Scholar]
  11. Lifson J. D., Feinberg M. B., Reyes G. R., Rabin L. R., Banapour B., Chakrabarti S., Moss B., Wong-Staal F., Steimer K., Engleman E. G. 1986b; Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature, London 323:725–728
    [Google Scholar]
  12. Lifson J. D., Hwang K. M., Nara P. L., Fraser B., Padgett M., Dunlop N. M., Eiden L. E. 1988; Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathogenicity. Science 241:712–716
    [Google Scholar]
  13. Mcdougal J. S., Kennedy M. S., Sligh J. M., Cort S. P., Mawle A, Nicholson K. A. 1986; Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science 231:382–385
    [Google Scholar]
  14. Mitsuya H., Looney D. J., Kuno S., Ueno R., Wong-Staal F., Broder S. 1988; Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells. Science 240:646–649
    [Google Scholar]
  15. Montefiori D. C., Robinson W. E. Jr, Schuffman S. S., Mitchell W. M. 1988; Evaluation of antiviral drugs and neutralizing antibodies to human immunodeficiency virus by a rapid and sensitive microtiter infection assay. Journal of Clinical Microbiology 26:231–235
    [Google Scholar]
  16. Nakashima H., Tochikura T., Kobayashi N., Matsuda A., Ueda T., Yamamoto N. 1987; Effect of 3′-azido-2′, 3′-dideoxythymidine (AZT) and neutralizing antibody on human immunodeficiency virus (HIV-induced cytopathic effects: implication of giant cell formation for the spread of virus in vivo. Virology 259:169–173
    [Google Scholar]
  17. Nakashima H., Tanabe A., Tochikura T. S., Yamamoto N. 1988; Rapid screening method with a cell multisizer for inhibitors of human immunodeficiency virus-induced cell fusion in vitro. Journal of Clinical Microbiology 26:1229–1232
    [Google Scholar]
  18. Pauwels R., De Clercq E., Desmyter J., Balzarini J. K., Goubau P., Herdewijn P., Vanderhaeghe H., Vandeputte M. 1987; Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus. Journal of Virological Methods 16:179–185
    [Google Scholar]
  19. Pauwels R., Balzarini J., Baba M., Snoeck R., Schols D., Herdewijn P., Desmyter I., De Clercq E. 1988; Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. Journal of Virological Methods 20:309–321
    [Google Scholar]
  20. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. 1984; Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497–500
    [Google Scholar]
  21. Sattentau Q. J., Dalgleish A. G., Weiss R. A., Beverley P. C. L. 1986; Epitopes of the CD4 antigen and HIV infection. Science 234:1120–1127
    [Google Scholar]
  22. Schols D., Pauwels R., Vanlangendonck F., Balzarini J., De clercq E. 1988; A highly reliable, sensitive, flow cytometric/fluorometric assay for the evaluation of the anti-HIV activity of antiviral compounds in MT- 4 cells. Journal of Immunological Methods 114:27–32
    [Google Scholar]
  23. Schols D., Baba M., Pauwels R., De Clercq E. 1989a; Flow cytometric method to demonstrate whether anti- HIV-1 agents inhibit virion binding to T4+ cells. Journal of Acquired Immune Deficiency Syndromes 2:10–15
    [Google Scholar]
  24. Schols D., Baba M., Pauwels R., Desmyter J., De Clercq E. 1989b; Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor. Proceedings of the National Academy of SciencesU.S.A. 86:3322–3326
    [Google Scholar]
  25. Skinner M. A., Ting R., Langlois A. J., Weinhold k. J., Lyerly H. K., Javaherian K., Matthews T. J. 1988; Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein. AIDS Research and Human Retroviruses 4:187–197
    [Google Scholar]
  26. Sodroski J., Goh W. C., Rosen C., Campbell K., Haseltine W. A. 1986; Role of the HLTV-III/LAV envelope in syncytium formation and cytopathicity. Nature, London 322470–474
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-70-9-2397
Loading
/content/journal/jgv/10.1099/0022-1317-70-9-2397
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error